Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thrombolysis. An approach still on the move.

× No keyword cloud information.

50 in total

1. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.

Authors: D C Stump; H R Lijnen; D Collen
Journal: J Biol Chem Date: 1986-12-25 Impact factor: 5.157

2. Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents.

Authors: D Collen; D C Stump; F Van de Werf
Journal: Am Heart J Date: 1986-11 Impact factor: 4.749

3. Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.

Authors: F Van de Werf; J Vanhaecke; H de Geest; M Verstraete; D Collen
Journal: Circulation Date: 1986-11 Impact factor: 29.690

4. Intracoronarily administered prostacyclin and streptokinase for treatment of myocardial infarction.

Authors: G Blaskó; E Berentey; A Harsányi; G Sas
Journal: Adv Prostaglandin Thromboxane Leukot Res Date: 1983

5. Antibody-directed urokinase: a specific fibrinolytic agent.

Authors: C Bode; G R Matsueda; K Y Hui; E Haber
Journal: Science Date: 1985-08-23 Impact factor: 47.728

6. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.

Authors: D Gheysen; H R Lijnen; L Piérard; F de Foresta; E Demarsin; P Jacobs; M De Wilde; A Bollen; D Collen
Journal: J Biol Chem Date: 1987-08-25 Impact factor: 5.157

7. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors: J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal: Circulation Date: 1987-07 Impact factor: 29.690

8. Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarction.

Authors: B Sharma; R P Wyeth; H J Gimenez; J A Franciosa
Journal: Am J Cardiol Date: 1986-12-01 Impact factor: 2.778

9. Laboratory monitoring of hemostasis during thrombolytic therapy with recombinant human tissue-type plasminogen activator.

Authors: H D Garabedian; H K Gold; R C Leinbach; T Yasuda; J A Johns; D Thornton; D Collen
Journal: Thromb Res Date: 1988-04-01 Impact factor: 3.944

10. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors: F Van de Werf; A E Arnold
Journal: BMJ Date: 1988-11-26

2 in total

Review 1. Intravenous streptokinase. A reappraisal of its therapeutic use in acute myocardial infarction.

Authors: K L Goa; J M Henwood; J F Stolz; M S Langley; S P Clissold
Journal: Drugs Date: 1990-05 Impact factor: 9.546

Review 2. Streptokinase. A review of its pharmacology and therapeutic efficacy in acute myocardial infarction in older patients.

Authors: P E Battershill; P Benfield; K L Goa
Journal: Drugs Aging Date: 1994-01 Impact factor: 3.923

2 in total